Kee Pharma Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1991.
1991 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Kee Pharma Limited

Kee Pharma Limited, a active public limited company, was established on 08 May 1991 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL1991PLC044264. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.48 Cr.

Formerly known as Kee Pharma P Limited. It upholds a compliant status. Employing 222 professional, Its leadership includes Anil Motihar (Managing Director), Harinder Motihar (Director), Mohit S Nigam (Additional Director). Past directors included Anil Motihar, Harinder Motihar, Taresh Verma. It holds ₹9.50 Cr open charges and ₹4.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A - 8, 3Rd Floor, Naraina Industrial Area, Phase - Ii,, New Delhi, Delhi, 110028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL1991PLC044264

  • Registration Number

    044264

  • Incorporation Date

    08 May 1991

  • Authorized Capital

    ₹11.00 Cr

  • Paid-Up Capital

    ₹10.48 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 10.48 Cr
  • Company Age 35 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 9.50 Cr
  • Satisfied Charges ₹ 4.50 Cr
Company report

Kee Pharma Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Kee Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kee Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Anil Motihar Managing Director 09 Nov 1992 Current
Harinder Motihar Director 31 Dec 2015 Current
Mohit S Nigam Additional Director 15 Dec 2025 Current
Natasha Goyal Director 22 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Company Secretary 04 Sep 2007 Past
Pramod Abcsdd Director 05 Nov 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 31 Dec 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kee Pharma.

Kee Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Kee Pharma revenue growth over time
Kee Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kee Pharma?

In 2023, Kee Pharma had a promoter holding of 84.65% and a public holding of 15.35%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹94,980,000.00

Satisfied Charges

₹45,000,000.00

Charges Breakdown by Lending Institutions
  • Indian Bank : 5.80 Cr
  • Nidian Bank : 1.80 Cr
  • Hsidc : 0.96 Cr
  • Haryana State Industrial Development Cor. Ltd. : 0.90 Cr
  • Ge Capital Services India : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
07 Oct 2004 Indian Bank ₹2.95 Cr Open
11 Sep 2003 Ge Capital Services India ₹0.45 M Open
18 Oct 2002 Nidian Bank ₹7.50 M Open
20 Oct 2000 Nidian Bank ₹1.00 Cr Open
26 Dec 1999 Indian Bank ₹0.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Kee Pharma?

Kee Pharma has a workforce of 222 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kee Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kee Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kee Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Mohit S Nigam was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2025 & has been associated with this company since 6 months 18 days . was completed.

  • Director Appointment

    The activity Natasha Goyal was appointed as a Director was appointed as a Director on 22 Jul 2025 & has been associated with this company since 11 months 11 days . was completed.

  • Annual General Meeting

    The activity Kee Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Kee Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Anil Motihar was appointed as a CFO was appointed as a CFO on 03 Apr 2019 & has been associated with this company since 7 years 3 months . was documented.

  • Director Appointment

    The activity Harinder Motihar was appointed as a Director was appointed as a Director on 31 Dec 2015 & has been associated with this company since 10 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kee Pharma Limited?

The CIN of Kee Pharma Limited is U24239DL1991PLC044264.

Where is Kee Pharma Limited headquartered?

Kee Pharma Limited is headquartered at A - 8, 3Rd Floor, Naraina Industrial Area, Phase - Ii,, New Delhi, Delhi, 110028.

When was Kee Pharma Limited incorporated?

Kee Pharma Limited was incorporated on 08 May 1991.

Who are the current directors of Kee Pharma Limited?

The current directors of Kee Pharma Limited are

What is the primary industry of Kee Pharma Limited?

The primary industry of Kee Pharma Limited is Manufacturing.

Is Kee Pharma Limited a listed company?

Kee Pharma Limited is unlisted.

What is the capital structure of Kee Pharma Limited?

The authorized capital of Kee Pharma Limited is ₹11.00 Cr, and the paid-up capital is ₹10.48 Cr.

What is the compliance status of Kee Pharma Limited?

The compliance status of Kee Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available